Without a doubt, the dream short-term trade comes when an analyst downgrades a winning stock because of "valuation" or because it reached his price target.I think it's a simpler trade. If big money wants to invest in biotech, there are only two large cap options - AMGN and DNA both around $100 bill. The next tier is stocks like GILD, GENZ and CELG in the mid-cap ($8-$20 bill) range. And then you're under $5 bill for everyone else.Big money can't fit into the small caps - gotta go somewhere.-chris
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat